A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1–T146

Reinstating tissue-specific tolerance has attracted much attention as a means to treat autoimmune diseases. However, despite promising results in rodent models of autoimmune diseases, no established tolerogenic therapy is clinically available yet. In the experimental autoimmune myasthenia gravis (EA...

Descripción completa

Detalles Bibliográficos
Autores principales: Consonni, Alessandra, Sharma, Sapna, Schön, Karin, Lebrero-Fernández, Cristina, Rinaldi, Elena, Lycke, Nils Yngve, Baggi, Fulvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604076/
https://www.ncbi.nlm.nih.gov/pubmed/28959261
http://dx.doi.org/10.3389/fimmu.2017.01133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604076/
https://www.ncbi.nlm.nih.gov/pubmed/28959261
http://dx.doi.org/10.3389/fimmu.2017.01133

Ejemplares similares